Latest Articles about ANAC

Wider-Than-Expected Loss at Anacor - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 00:06:46 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) reported first quarter 2013 net loss per share of 42 cents, wider than the Zacks Consensus Estimate of a loss of 34 cents but narrower than the

Anacor, Gates Foundation Collaborate - Analyst Blog

Zacks Equity Research — Wed, 10 Apr 2013 02:10:26 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) inked a deal with the Bill & Melinda Gates Foundation for the discovery of drug candidates for the treatment of two filarial worm diseases

Encouraging Data on Anacor's AN2728 - Analyst Blog

Zacks Equity Research — Sat, 23 Mar 2013 02:27:07 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) recently announced positive results from a phase II dose-ranging study conducted in adolescents for its atopic dermatitis candidate, AN2728. The

Loss at Anacor Pharma Narrower-Than-Expected - Analyst Blog

Zacks Equity Research — Fri, 15 Mar 2013 16:44:00 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) reported fourth-quarter 2012 net loss per share of 36 cents, narrower than the Zacks Consensus Estimate of a loss of 44 cents and the year-ago loss of

After-Hours Earnings Report for March 14, 2013 : ULTA, BCEI, ARO, KKD, MCP, ZUMZ, HOGS, ULTR, OMPI, CPE, ANAC, LPR

NASDAQ.com News — Thu, 14 Mar 2013 22:00:04 Z

The following companies are expected to report earnings after hours on 03/14/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Ulta Salon, Cosmetics &

Positive Data on Anacor Candidate - Analyst Blog

Zacks Equity Research — Sat, 02 Mar 2013 02:28:50 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) recently announced positive preliminary results on tavaborole (AN2690) from Study 302. Tavaborole is being developed for the prevention of

Data on Anacor Candidate - Analyst Blog

Zacks Equity Research — Thu, 31 Jan 2013 04:18:47 Z

Anacor Pharmaceuticals, Inc. ( ANAC ) recently announced positive preliminary results on tavaborole (AN2690) from Study 301. Tavaborole is being developed for the prevention of

Pre-Market Most Active for Jan 29, 2013 : F, SHO, EMC, ANAC, EXC, BAC, YHOO, VMW, FB, QQQ, ERIC, VOD

NASDAQ.com News — Tue, 29 Jan 2013 18:40:00 Z

The NASDAQ 100 Pre-Market Indicator is up 3.75 to 2,746.18. The total Pre-Market volume is currently 16,235,518 shares traded. The following are the most active stocks for the pre-market

Questcor Acquires BioVectra - Analyst Blog

Zacks Equity Research — Wed, 23 Jan 2013 02:00:01 Z

Questcor Pharmaceuticals Inc. ( QCOR ) recently announced that it has completed the acquisition of BioVectera Inc. for an immediate cash payment of CAD 50 million ($50.40 million

Synergy/Callisto Merger Approved - Analyst Blog

Zacks Equity Research — Fri, 18 Jan 2013 02:40:01 Z

Synergy Pharmaceuticals Inc. 's ( SGYP ) stockholders recently approved Synergy Pharma's merger with Callisto Pharmaceuticals Inc. The deal was initially announced in Jul 2012 and later

Upcoming Catalysts For Anacor Pharma Should Make For Strong Upside Gains

Trefis Team — Wed, 28 Nov 2012 04:05:55 Z

Submitted by Scott Matusow as part of our contributors program . Trading biophama companies before a catalyst event, if done correctly, can be a very profitable proposition. Some traders

RNP-AR-Approach Boosts GOL - Analyst Blog

Zacks Equity Research — Sat, 12 May 2012 03:06:45 Z

Recently, GOL Linhas Aéreas Inteligentes ( GOL ) has been declared to be the first Brazilian airline to use RNP-AR-Approach (Required Navigation Performance). This environment

Stocks Pointed Higher with Retail Sales, Fed in Focus

Schaeffer's Investment Research — Tue, 13 Mar 2012 16:30:17 Z

Despite yesterday's concerns over China's wider-than-expected trade gap , the bulls eventually emerged, with the Dow Jones Industrial Average (DJIA) and S&P 500 Index (SPX)

Medicis Completes Graceway Purchase - Analyst Blog

Zacks Equity Research — Sat, 18 Feb 2012 03:07:01 Z

Medicis Pharmaceutical Corp. ( MRX ) recently announced that it has completed the acquisition of Graceway Pharmaceuticals, LLC. In November last year, Medicis first announced that it

Tuesday's Top Performing Small Cap Stocks (PNX, ANAC, FRP, NOG, MAKO)

(Wyatt Research Staff) — Wed, 10 Aug 2011 20:06:25 Z

The late-session snapback rally on Tuesday brought stocks back from the depths of Monday's losses, but many observers still say that we're not out of the woods yet. What's stalking